1[1]Goldberg RM,Sargent DJ,Morton RF,et al.A randomized controlled trial of fluorouracil plus leucovorin,irinotecan,and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer.J Clin Oncol,2004,22:23-30
2[2]Tournigand C,Andre T,Achille E,et al:FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer:A randomized GERCOR study.J Clin Oncol,2004,22:229-237
3[3]Hurwitz H,Fehrenbacher L,Novotny W,et al.Bevacizumab plus irinotecan,fluorouracil,and leucovorin for metastatic colorectal cancer.N Engl J Med,2004,350:2335-2342
4[4]B.J.Giantonio BJ,Catalano PJ,Meropol NJ,et al.High-dose bevacizumab in combination with FOLFOX4 improves survival in patients with previously treated advanced colorectal cancer.Results from the Eastern Cooperative Oncology Group (ECOG)study E3200.Gastrointestinal Cancers Symposium,2005,Abstract 169a
5[5]H.S.Hochster LW,L.Hart,R.K.Ramanathan,J.Hainsworth,G.Jirau-Lucca,A.Shpilsky,S.Griffing,R.Mass,D.Emanuel.Safety and efficacy of bevacizumab (Bev) when added to oxaliplatin/fluoropyrimidine (O/F) regimens as first-line treatment of metastatic colorectal cancer (mCRC):TREE 1 & 2 Studies.Annual ASCO Meeting,2005,Abstract 3515
6[6]Kabbinavar FF,Hambleton J,Mass RD,Hurwitz HI,Bergsland E,Sarkar S.Combined Analysis of Efficacy:The Addition of Bevacizumab to Fluorouracil/Leucov orin Improves Survival for Patients With Metastatic Colorectal Cancer.J Clin Oncol,2005,23 (16):3706-3712
7[7]Moertel CG,Fleming TR,Macdonald JS,et al.Levamisole and fluorouracil as adjuvant therapy of resected colon carcinoma.N Engl J Med,1990,322 (6):352-358
8[8]Andre T,Boni C,Mounedji-Boudiaf L et al.Oxaliplatin,fluorouracil,and leucovorin as adjuvant treatment for colon cancer.N Engl J Med,2004,350 (23):2343-2351
9[9]A.de Gramont CB,M.Navarro,J.Tabernero,T.Hickish,C.Topham,A.Bonetti,P.Clingan,J.Marceau-Suissa,C.Lorenzato,T.André Oxaliplatin/5FU/LV In the Adjuvant Treatment of Stage Ⅱ and Stage Ⅲ Colon Cancer:.Efficacy results with a median follow-up of 4 years.Annual ASCO Meeting.2005; Abstract 3501
10[10]Sargent DJ,Wieand HS,Haller DG,et al.Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies:Individual patient data from 20 898 patient on 18 randomized trials.J Clin Oncol,2005,23 (34):8664-8670
